Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 6, 2007, Pages 382-389

  Jak, Amy J ^a,b   Houston, Wes S ^c   Nagel, Bonnie J ^d   Corey Bloom, Jody ^b,e   Bondi, Mark W ^b,f,g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein E 4 allele; Cognitive performance; Hippocampal volume

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; BRAIN SIZE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; BRAIN; COGNITION; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; REFERENCE VALUES;

EID: 34250163241     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101340     Document Type: Article

References (38)

1. Poulin P, Zakzanis KK: In vivo neuroanatomy of Alzheimer's disease: evidence from structural and functional brain imaging. Brain Cogn 2002;49:220-225.
2. Geroldi C, Pihlajamaki M, Laakso MP, et al: APOE-epsilon 4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 1999;53:1825-1832.
3. Tohgi H, Takahashi S, Kato E, et al: Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon 4 allele. Neurosci Lett 1997;236:21-24.
4. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MMB: Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002;59:746-748.
5. Plassman BL, Welsh-Bohmer KA, Bigler ED, et al: Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 1997;48:985-989.
6. Jernigan TL, Archibald SL, Fennema-Notestine C, et al: Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 2001;22:581-894.
7. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T: Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 2001;57:2223-2228.
8. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM: Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 2000;55:134-136.
9. Reiman EM, Ueker A, Caselli RJ, et al: Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998;44:288-291.
10. Tupler LA, Krishnan KRR, Greenberg DL, et al: Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve. Neurobiol Aging, Epub ahead of print.
11. Serra-Grabulosa JM, Salgado-Pineda P, Junque C, et al: Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics 2003;4:141-146.
12. Pedraza O, Bowers D, Gilmore R: Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults. J Int Neuropsychol Soc 2004;10:664-678.
13. Soininen H, Partanen K, Pitkanen A, et al: Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon4 allele. Neurology 1995;45:391-392.
14. Geroldi C, Laakso MP, DeCarli C, et al: Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry 2000;68:93-96.
15. Bigler ED, Tate DF, Miller MJ, et al: Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment. J Int Neuropsychol Soc 2002;8:925-933.
16. Lye TC, Piguet O, Grayson DA, et al: Hippocampal size and memory function in the ninth and tenth decades of life: the Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 2004;75:548-554.
17. Hackert VH, den Heijer T, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MMB: Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage 2002;17:1365-1372.
18. Walhovd KB, Fjell AM, Reinvang I, et al: Size does matter in the long run: hippocampal and cortical volume predict recall across weeks. Neurology 2004;63:1193-1197.
19. Mortimer JA, Gosche KM, Riley KP, Markesbery WR, Snowdon DA: Delayed recall, hippocampal volume and Alzheimer neuropathology. Neurology 2004;62:428-432.
20. Ylikoski R, Salonen O, Mantyla R, et al: Hippocampal and temporal lobe atrophy and age-related decline in memory. Acta Neurol Scand 2000;101:273-278.
21. Basso M, Yang J, Warren L, et al: Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Res 2006;146:251-261.
22. Persson J, Nyberg L, Lind J, et al: Structure-function correlates of cognitive decline in aging. Cereb Cortex 2006;16:907-915.
23. Petersen RC, Jack CR, Xu Y-C, et al: Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000;54:581-587.
24. Bartres-Faz D, Junque C, Clemente IC, et al: MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol Aging 2001;22:449-459.
25. Mungas D, Harvey D, Reed BR, et al: Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005;65:565-571.
26. Devanand DP, Pelton GH, Zamora D, et al: Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol 2005;62:975-980.
27. Wilson RS, Schneider JA, Barnes LL, et al: The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002;59:1154-1160.
28. Mattis S: Dementia Rating Scale: Professional Manual. Odessa, Psychological Assessment Resources, 1988.
29. Wechsler D: Wechsler Memory Scale - Revised. New York, Psychological Corporation, 1987.
30. Delis DC, Kramer JH, Kaplan E, Ober BA: The California Verbal Learning Test. New York, Psychological Corporation, 1987.
31. Twamley EW, Ropacki SAL, Bondi MW: Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2006;12:707-735.
32. Loeb PA: ILS: Independent Living Scales Manual. San Antonio, Psychological Corp, Harcourt Brace Jovanovich, 1996.
33. Heaton RK, Grant I, Matthews CG: Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, Psychological Assessment Resources, 1991.
34. Petersen RC, Morris JC: Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160-1163.
35. Nagel BJ, Palmer SL, Reddick WE, et al: Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation Am J Neuroradiol 2004;25:1575-1582.
36. Bigler ED, Tate DF: Brain volume, intracranial volume, and dementia. Invest Radiol 2001;36:539-546.
37. Geuze E, Vermetten E, Bremmer JD: MR-based in vivo hippocampal volumetrics. 1. Review of methodologies currently employed. Mol Psychiatry 2005;10:147-159.
38. Salmon DP, Thomas RG, Pay MM, et al: Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology 2002;59:1022-1028.